Luminex Corp (LMNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

12212 TECHNOLOGY BLVD AUSTIN, TX 78727

The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.

Data as of 2021-05-01 09:56:57 -0400
Market Cap1.736 Billion Shares Outstanding47.304 Million Avg 30-day Volume2.268 Million
P/E Ratio116.70222 Dividend Yield1.031 EPS0.325
Price/Sales4.16 Debt to Equity1.59 EBITDA52.394 Million
Price to Book Value3.35 Forward PE41.59 Enterprise Value1.63 Billion
Total Cash309.407 Million Current Debt87.461 Million Gross Profit247.852 Million
BETA0.11299 52-week High/Low41.25 / 20.47 Next Earnings Date2021-05-03 Price to Cash FLow (P/CF) 469.7174
Data provided by IEX Cloud
View SEC Filings from LMNX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 200 211 -5.21% 51 (3.06%) 71 (4.42%) -28.17%
13F shares: 40.815 Million 42.451 Million -3.85% 12.825 Million 15.963 Million -19.66%
% Ownership 87.7265 91.2425 -3.85% 27.5648 34.3094 -19.66%
New Positions: 31 40 -22.5% 7 17 -58.82%
Increased Positions 78 77 1.3% 21 20 5.0%
Closed Positions 41 33 24.24% 26 13 100.0%
Reduced Positions 65 64 1.56% 17 28 -39.29%
Total Calls 77.832 Thousand 116.789 Thousand -33.36% 53.4 Thousand 42.8 Thousand 24.77%
Total Puts 118.459 Thousand 58.575 Thousand 102.23% 93.5 Thousand 18.7 Thousand 400.0%
PUT/CALL Ratio 1.52 0.5 204.0% 1.75 0.44 297.73%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LMNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LMNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FAIRCHILD NANCY SVP, HUMAN RESOURCES

  • Officer
100,223 2021-03-12 6

COLLINS CHARLES J. SR VP, R&D - US

  • Officer
114,371 2021-03-12 3

SHAPIRO ERIC SR VP, GLOBAL MARKETING

  • Officer
97,403 2021-03-12 2

CURRIE HARRISS T SVP, FINANCE & CFO

  • Officer
329,120 2021-03-11 2

SHAMIR NACHUM PRESIDENT & CEO

  • Officer
  • Director
1,068,551 2021-03-11 2

REW RICHARD W. II SVP, GEN COUNSEL & CORP SECY

  • Officer
145,655 2021-03-11 3

MYERS RANDALL SVP, GLOBAL MFG AND QUALITY

  • Officer
154,734 2021-03-11 3

BENNETT TODD C. SVP, GLOBAL SALES & CUST OPS

  • Officer
120,555 2021-03-11 2

ECK STEPHEN L.

  • Director
37,807 2020-11-25 3

OGUNRO EDWARD A

  • Director
60,394 2020-10-09 2

LOEWENBAUM G WALTER II

  • Director
1,684,990 2020-08-04 8

MCNAMARA KEVIN M

  • Director
98,293 2020-06-01 1

KEVER JIM D

  • Director
229,295 2020-06-01 1

ERICKSON THOMAS W

  • Director
185,806 2020-06-01 1

SAMET KENNETH A

  • Director
19,620 2020-06-01 1

LEWIS DIJUANA K

  • Director
6,955 2020-06-01 1

CRESCI ROBERT J

  • Director
220,157 2018-05-17 0

LAZARUS TADD S. SVP, CHIEF MEDICAL OFFICER

  • Officer
10,495 2017-03-10 0

JOHNSTON JAY B

  • Director
146,696 2016-05-19 0

BRADLEY RUSSELL W SVP, CORP DEV & CMO

  • Officer
100,667 2016-03-22 0

GOAD FRED C JR

  • Director
300,767 2015-05-14 0

BRIDGE-COOK JEREMY K SVP, RESEARCH AND DEVELOPMENT

  • Officer
74,273 2015-03-12 0

BALTHROP PATRICK J PRESIDENT & CEO

  • Officer
  • Director
646,873 2014-05-14 0

REITER DAVID S SVP & GENERAL COUNSEL

  • Officer
60,400 2014-05-01 0

PINTEK MICHAEL F SVP, OPERATIONS

  • Officer
62,236 2014-03-13 0

DEHNE TIMOTHY R VP, SYSTEMS R&D

  • Officer
20,441 2013-08-16 0

VAILLANT GERARD

  • Director
61,842 2012-05-23 0

GOSCH GREGORY J VP, BIOSCIENCE GROUP

  • Officer
55,380 2010-05-13 0

THOMPSON J STARK PHD

  • Director
18,289 2008-11-26 0

CARRANO JOHN C VP, RESEARCH & DEVELOPMENT

  • Officer
43,913 2008-11-17 0

BRYANT DOUGLAS C EVP, CHIEF OPERATING OFFICER

  • Officer
68,428 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MYERS RANDALL - Officer SVP, GLOBAL MFG AND QUALITY

2021-03-16 18:07:12 -0400 2021-03-12 A 72,976 $23.09 a 72,976 direct

SHAPIRO ERIC - Officer SR VP, GLOBAL MARKETING

2021-03-15 20:36:15 -0400 2021-03-12 A 51,084 $23.09 a 51,084 direct

CURRIE HARRISS T - Officer SVP, FINANCE & CFO

2021-03-15 16:51:26 -0400 2021-03-12 A 18,620 $32.76 a 243,170 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2021-03-15 16:51:50 -0400 2021-03-12 A 66,490 $23.09 a 66,490 direct

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2021-03-15 16:52:11 -0400 2021-03-12 F 7,696 $32.76 d 179,210 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

BENNETT TODD C. - Officer SVP, GLOBAL SALES & CUST OPS

2021-03-15 16:51:05 -0400 2021-03-12 A 16,788 $32.76 a 47,579 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

COLLINS CHARLES J. - Officer SR VP, R&D - US

2021-03-17 10:49:50 -0400 2021-03-12 A 64,868 $23.09 a 64,868 direct

MYERS RANDALL - Officer SVP, GLOBAL MFG AND QUALITY

2021-03-16 18:07:12 -0400 2021-03-12 A 16,788 $32.76 a 49,511 direct -3.6039 -8.5848 7.7864 8.8445 18 -8.5848 6

FAIRCHILD NANCY - Officer SVP, HUMAN RESOURCES

2021-03-16 13:58:49 -0400 2021-03-12 A 53,516 $23.09 a 53,516 direct

SHAPIRO ERIC - Officer SR VP, GLOBAL MARKETING

2021-03-15 20:36:15 -0400 2021-03-12 A 12,057 $32.76 a 46,319 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

CURRIE HARRISS T - Officer SVP, FINANCE & CFO

2021-03-15 16:51:26 -0400 2021-03-12 F 1,939 $32.76 d 224,550 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2021-03-15 16:51:50 -0400 2021-03-12 A 14,957 $32.76 a 47,272 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2021-03-15 16:52:11 -0400 2021-03-12 A 648,686 $23.09 a 648,686 direct

BENNETT TODD C. - Officer SVP, GLOBAL SALES & CUST OPS

2021-03-15 16:51:05 -0400 2021-03-12 F 2,875 $32.76 d 30,791 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

COLLINS CHARLES J. - Officer SR VP, R&D - US

2021-03-17 10:49:50 -0400 2021-03-12 A 14,652 $32.76 a 49,503 direct -3.6039 -8.5848 7.7864 8.8445 18 -8.5848 6

MYERS RANDALL - Officer SVP, GLOBAL MFG AND QUALITY

2021-03-16 18:07:12 -0400 2021-03-12 F 1,596 $32.76 d 32,247 direct -3.6039 -8.5848 7.7864 8.8445 18 -8.5848 6

FAIRCHILD NANCY - Officer SVP, HUMAN RESOURCES

2021-03-16 13:58:49 -0400 2021-03-12 A 12,515 $32.76 a 46,707 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

CURRIE HARRISS T - Officer SVP, FINANCE & CFO

2021-03-15 16:51:26 -0400 2021-03-12 A 85,950 $23.09 a 85,950 direct

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2021-03-15 16:51:50 -0400 2021-03-12 F 965 $32.76 d 31,893 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2021-03-15 16:52:11 -0400 2021-03-12 A 61,050 $32.76 a 240,655 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

BENNETT TODD C. - Officer SVP, GLOBAL SALES & CUST OPS

2021-03-15 16:51:05 -0400 2021-03-12 A 72,976 $23.09 a 72,976 direct

BENNETT TODD C. - Officer SVP, GLOBAL SALES & CUST OPS

2021-03-15 16:51:05 -0400 2021-03-11 F 531 $32.45 d 33,666 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

MYERS RANDALL - Officer SVP, GLOBAL MFG AND QUALITY

2021-03-16 18:07:12 -0400 2021-03-11 F 295 $32.45 d 33,843 direct -3.6039 -8.5848 7.7864 8.8445 18 -8.5848 6

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2021-03-15 16:51:50 -0400 2021-03-11 F 295 $32.45 d 32,858 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2021-03-15 16:52:11 -0400 2021-03-11 F 2,726 $32.45 d 186,906 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

CURRIE HARRISS T - Officer SVP, FINANCE & CFO

2021-03-15 16:51:26 -0400 2021-03-11 F 379 $32.45 d 226,489 direct 1.1259 -3.9407 9.0304 10.0707 19 -7.2588 7

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LUMINEX CORP LMNX 2021-05-05 22:15:02 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 21:45:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 21:15:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 20:45:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 20:15:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 19:45:02 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 19:15:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 18:45:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 18:15:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 17:45:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 17:15:03 UTC -0.5405 0.5905 2700000
LUMINEX CORP LMNX 2021-05-05 16:45:03 UTC -0.5313 0.5813 2700000
LUMINEX CORP LMNX 2021-05-05 16:15:03 UTC -0.5313 0.5813 2700000
LUMINEX CORP LMNX 2021-05-05 15:45:03 UTC -0.5313 0.5813 2700000
LUMINEX CORP LMNX 2021-05-05 15:15:02 UTC -0.5313 0.5813 2700000
LUMINEX CORP LMNX 2021-05-05 14:45:04 UTC -0.5506 0.6006 2700000
LUMINEX CORP LMNX 2021-05-05 14:15:03 UTC -0.5506 0.6006 2700000
LUMINEX CORP LMNX 2021-05-05 13:45:03 UTC -0.5506 0.6006 2700000
LUMINEX CORP LMNX 2021-05-05 13:15:03 UTC -0.5506 0.6006 2700000
LUMINEX CORP LMNX 2021-05-05 12:45:02 UTC -0.5506 0.6006 2700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Defensive Long Fund LMNX -105.0 shares, $-2890.65 2020-03-31 N-PORT

Elevate your investments